MACK Stock Summary and Trading Ideas (Merrimack Pharmaceuticals | NASDAQ:MACK)

Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.

Merrimack Pharmaceuticals trades on the NASDAQ stock market under the symbol MACK.

As of April 18, 2024, MACK stock price was flat at $14.68 with 111,347 million shares trading.

MACK has a beta of 0.25, meaning it tends to be less sensitive to market movements. MACK has a correlation of 0.04 to the broad based SPY ETF.

MACK has a market cap of $213.33 million. This is considered a Small Cap stock.

In the last 3 years, MACK stock traded as high as $15.89 and as low as $3.00.

The top ETF exchange traded funds that MACK belongs to (by Net Assets): VTI, DWAS, IWM, VXF, IWO.

MACK stock has underperformed the market in the last year with a return of +15.0%, while SPY returned +22.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MACK shares. However, MACK has outperformed the market in the last 3 month and 2 week periods, returning +11.5% and -0.2%, while SPY returned +6.1% and -3.8%, respectively. This indicates MACK has been having a stronger performance recently.

MACK support price is $14.62 and resistance is $14.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MACK stock will trade within this expected range on the day.